Search

Your search keyword '"Arenas Prat, M."' showing total 19 results
Start Over Author "Arenas Prat, M."
19 results on '"Arenas Prat, M."'

2. PO-1562 Radiotherapy treatment in non melanoma skin cancer (NMSC)

Author

Árquez Pianetta, M., primary, Arguís Pinel, M., additional, Ejimeno Castejín, A., additional, Gómez Gómez, D., additional, Murcia, M., additional, Castaño Zuleta, F.A., additional, López, Y., additional, Trilla, J., additional, Malavé Chacón, B., additional, Calderón, D., additional, Torres Royo, L., additional, Escuin Troncho, C., additional, Engel, O., additional, Santafé, A., additional, Araguás Mora, P., additional, Acosta Arteaga, J., additional, Reventóz Martínez, F., additional, and Arenas Prat, M., additional

Published
2023
Full Text
View/download PDF

3. PD-0968 Treatment of COVID-19 pneumonia with low-dose radiotherapy in frail patients

Author

Malave Chacon, B.A., primary, Acosta Arteaga, J.C., additional, Piqué, B., additional, Torres-Royo, L., additional, Rodríguez-Tomás, E., additional, Benavides, R., additional, De Febrer, G., additional, Araguas, P., additional, Gomez, J.A., additional, Arquez, M., additional, Calderon, V.D., additional, Algara, M., additional, Montero, A., additional, Parada, D., additional, Riu, F., additional, Jiménez, A., additional, Vasco, C., additional, Sabater, S., additional, Camps, J., additional, Joven, J., additional, and Arenas Prat, M., additional

Published
2023
Full Text
View/download PDF

5. PO-1222: Radiotherapy for non-melanoma skin cancer: three different radiation techniques comparison

Author

Arquez Pianetta, M., primary, Torres Royo, L., additional, Arguís Pinel, M., additional, Gómez Gómez, D., additional, López Sánchez, Y., additional, Castaño Zuleta, F., additional, Acosta Arteaga, J., additional, Gómez Ramos, J., additional, Murcia Mejía, M., additional, Azón, A., additional, Cabré Rubio, N., additional, and Arenas Prat, M., additional

Published
2020
Full Text
View/download PDF

6. Current functioning of cardio-oncology units in Spain

Author

Mitroi, C., primary, Martín-García, A., additional, Mazón Ramos, P., additional, Virizuela Echaburu, J. A., additional, Arenas-Prat, M., additional, García-Sanz, R., additional, Arrarte Esteban, V., additional, García-Pinilla, J. M., additional, Cosín-Sales, J., additional, and López-Fernández, T., additional

Published
2019
Full Text
View/download PDF

7. PO-1079 Metabolic changes with the administration of radiotherapy in lung, head and neck cancer patients

Author

Rodríguez-Tomàs, E., primary, Murcia, M., additional, Arguís, M., additional, Dolz, I., additional, De Abreu, M., additional, Baiges-Gaya, G., additional, Cabré, N., additional, Luciano-Mateo, F., additional, Torres-Royo, L., additional, Árquez, M., additional, Gómez, J., additional, Acosta, J., additional, Gómez, D., additional, Jordi, C., additional, Jorge, J., additional, Sabater, S., additional, and Arenas Prat, M., additional

Published
2019
Full Text
View/download PDF

8. should radiotherapy be avoided after neoadjuvant chemotherapy in complete response breast cancer?

Author

Universitat Rovira i Virgili, Arenas Prat, M.; Sabater, S.; Bonet, M.; Gascon, M.; Gomez, D.; Arquez, M.; Torres, L.; Gomez, J.; Amillano, K.; Mele, M.; De la Flor, M.; Rodriguez, E.; Camps, J.; Joven, J., Universitat Rovira i Virgili, and Arenas Prat, M.; Sabater, S.; Bonet, M.; Gascon, M.; Gomez, D.; Arquez, M.; Torres, L.; Gomez, J.; Amillano, K.; Mele, M.; De la Flor, M.; Rodriguez, E.; Camps, J.; Joven, J.

Published
2018

9. EP-2303: Should radiotherapy be avoided after neoadjuvant chemotherapy in complete response breast cancer?

Author

Arenas Prat, M., primary, Sabater, S., additional, Bonet, M., additional, Gascón, M., additional, Gómez, D., additional, Arquez, M., additional, Torres, L., additional, Gómez, J., additional, Amillano, K., additional, Melé, M., additional, De la Flor, M., additional, Rodríguez, E., additional, Camps, J., additional, and Joven, J., additional

Published
2018
Full Text
View/download PDF

17. Low-Dose radiation therapy for benign pathologies.

Author

Torres Royo L, Antelo Redondo G, Árquez Pianetta M, and Arenas Prat M

Abstract

Radiotherapy (RT) has always been a mainstay for malignant tumors therapy, but it is also used for benign pathology. The application of low or intermediate doses of RT has been widely studied. This topic was presented and discussed in the last XX GOCO (Grup Oncològic Català-Occità) meeting. The aim of this article is to review the indications of low dose irradiation (LD-RT), total dose and different fractionations, the public to whom it can be directed, and to offer an analysis about secondary effects. We believe it can be useful not only for radiation oncologists, but for other physicians to consider this option for future patients., (© 2020 Published by Elsevier B.V. on behalf of Greater Poland Cancer Centre.)

Published
2020
Full Text
View/download PDF

18. Brachytherapy in lip cancer.

Author

Rovirosa-Casino A, Planas-Toledano I, Ferre-Jorge J, Oliva-Díez JM, Conill-Llobet C, and Arenas-Prat M

Subjects
Humans, Brachytherapy adverse effects, Brachytherapy methods, Lip Neoplasms radiotherapy
Abstract

Lip cancer is one of the most prevalent skin tumours of the head and neck. The characteristics of the tumour relate to their exophyitic growth in an area of easy visual acces which allows their diagnosis in early stages. As a result, there is a better prognosis with the present treatments. In early stages the treatment can be performed by surgery or by brachytherapy, and the results are similar on local control; nevertheless brachytherapy offers the best functional and esthetic results. We are reporting on a review of the literature in relation to indications, techniques and results of brachytherapy for lip cancer.

Published
2006

19. [Prevalence and detection of depressive disorders in primary care].

Author

Gabarrón Hortal E, Vidal Royo JM, Haro Abad JM, Boix Soriano I, Jover Blanca A, and Arenas Prat M

Subjects
Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prevalence, Primary Health Care, Depressive Disorder epidemiology, Depressive Disorder prevention & control
Abstract

Aim: To study the prevalence of depression in primary care, the detection of depressive disorders by primary care physicians, and the factors that influence detection., Design: Cross-sectional, descriptive study., Setting: Gavà II Primary Care Center, in Barcelona, Spain., Participants: A total of 400 people between the ages of 18 and 65 years were chosen randomly from among those who attended appointments with their primary care physician., Main Measures: A sociodemographic questionnaire and the Beck Depression Inventory (BDI) screening test were administered, and the participant s medical record was reviewed. In a subsample of 40 participants, the Mini-International Neuropsychiatric Interview (MINI) was also administered. The optimum cutoff score for the BDI was estimated with reference to the MINI results., Results: A cutoff score of 20/21 for the BDI had a sensitivity of 86.7% and a specificity of 92%, when the MINI score was used as a reference. The adjusted prevalence of depressive disorder in our primary care setting was 20.2% overall, 8.1% in men, and 26.8% in women (odds ratio 4.15, p < 0.01). The physician detected depressive symptoms in 55.7% of all likely cases of depression. Persons who scored >= 21 on the BDI made more visits to their primary care physician, and had more stressful life events, than those who scored 20., Conclusions: The prevalence of depression in our primary care setting is high. The disorder was underdiagnosed in as many as 44.3% of the persons likely to have depressive disorder (especially women, widows and widowers, retired persons, persons who had experienced stressful life events, and frequent users of primary care services).

Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results